Service

Early detection of cancer.

BioPharma

The AlphaLiquid® platform enables enhanced safety, speed and efficiency in clinical trials for drug development

Key Value Proposition

  • Customized panel design services to fulfill clinical development needs
  • · Extensive oncology clinical network in Korea
  • · Professional support from IMBdx medical, R&D and bioinformatics teams
  • · Industry-leading assay performance at competitive prices
  • · Dedicated project manager for personalized real-time services with physician
  • · Real-Time tumor response monitoring to ensure patient safety during the clinical trial

Biopharma Collaborations